Disclosed are a specific chimeric antigen receptor targeting NKG2DL, a coding sequence thereof, and immune response cells modified by same, and the preparation method and use thereof. The modified immune response cells can effectively target and attack multiple tumour cells, in particular, positive tumour cells expressing NKG2DL, and can be used to prepare a preparation for treating tumours.